Patients who underwent surgery to repair punctured arteries had a significantly higher risk of complications when surgeons used a vascular-closure device manufactured by Cardinal Health, compared to ...
CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug ...
The Department of Medicine is proud to celebrate the Electrophysiology Team for being the first in the world to perform a procedure using a new vascular closure system. The new device helps stop ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that it will unveil the results of its U.S ...
Vivasure Medical Ltd. received CE mark approval for its Perqseal Elite vascular closure system which manages bleeding complications associated with large-bore arterial vessel closure. The sutureless, ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced initial positive results from its U.S. IDE ...
Earlier this week, Needham downgraded Haemonetics from “Buy” to “Hold,” pointing to intensifying competition in vascular closure devices from Abbott and Cordis and warning that this could weigh on the ...
DENVER, CO, UNITED STATES, March 5, 2025 /EINPresswire.com/ -- Secure Closure Inc. (SCI), an early stage medical device company developing the Quattro-Close™ a ...
TipRanks on MSN
Haemonetics downgraded to hold from buy at Needham
Needham downgraded Haemonetics (HAE) to Hold from Buy without a price target The firm’s checks indicate rising concern around competition for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback